Efficacy of Immune Checkpoint Inhibitors in Postoperative Recurrence of Wild-type EGFR Non-Small Cell Lung Cancer.
Imamura Y, Kato T, Nomata Y, Okado S, Watanabe H, Kawasumi Y, Nakanishi K, Kadomatsu Y, Ueno H, Nakamura S, Mizuno T, Hase T, Tanaka I, Ishii M, Yatsuya H, Chen-Yoshikawa TF.
Imamura Y, et al. Among authors: nakamura s.
Anticancer Res. 2024 Aug;44(8):3451-3461. doi: 10.21873/anticanres.17165.
Anticancer Res. 2024.
PMID: 39060057